Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients - Trial NCT06378853
Access comprehensive clinical trial information for NCT06378853 through Pure Global AI's free database. This phase not specified trial is sponsored by Jinling Hospital, China and is currently Completed. The study focuses on Pancreatic Cancer. Target enrollment is 548 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jinling Hospital, China
Timeline & Enrollment
N/A
Jan 01, 2019
Feb 28, 2024
Primary Outcome
complications,overall survival,risk factors
Summary
By evaluating the nutritional status of patients with pancreatic ductal adenocarcinoma (PDAC)
 admitted to Jinling Hospital, collecting relevant clinical data. we aim to conduct
 correlation analysis with patient clinical information, such as survival time,
 hospitalization time, nutritional status, hematological indicators, etc., in order to reveal
 the prognostic factors for overall survival and postoperative complications of PDAC patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06378853
Non-Device Trial